Clinical, molecular, and prognostic significance of WHO type inv(3)(q21q26.2)/t(3;3)(q21;q26.2) and various other 3q abnormalities in acute myeloid leukemia: A study of 6,515 cases of AML

S. Groschel, S. Lugthart, B.H. Beverloo, S. Kayser, P.J. Valk, S.L. Van Zelderen-Bhola, G.J. Ossenkoppele, E. Vellenga, E. van den Berg-de Ruiter, U. Schanz, G. Verhoef, A Ferrant, C.H. Kohne, M. Pfreundschuh, H.A. Horst, E. Koller, M. von Lilienfeld-Toal, M. Bentz, A. Ganser, B. SchlegelbergerM. Jotterand, J. Krauter, T. Pabst, M Theobald, R.F. Schlenk, R. Delwel, K. Dohner, B. Lowenberg, H. Dohner

Research output: Contribution to journalMeeting AbstractOther research output

Original languageUndefined/Unknown
Pages (from-to)6-6
JournalOnkologie
Volume33
Publication statusPublished - 2010

Cite this

Groschel, S., Lugthart, S., Beverloo, B. H., Kayser, S., Valk, P. J., Van Zelderen-Bhola, S. L., ... Dohner, H. (2010). Clinical, molecular, and prognostic significance of WHO type inv(3)(q21q26.2)/t(3;3)(q21;q26.2) and various other 3q abnormalities in acute myeloid leukemia: A study of 6,515 cases of AML. Onkologie, 33, 6-6.